Pipeline map including
next generation Matrix Therapies with RGTA®
liseret1
liseret2

Our Pipeline

Our Pipeline

1_Pipeline_Desktop_2022
3_Pipeline_Mobile_2022
logo_o

OTR3 focuses on high potential programs
including award winning key projects.

Our R&D
Projects

Our R&D
Projects

OTR3 focuses on key development projects with high potential, with the aim of exploiting the versatility of the RGTA® technology to provide to patients new healthcare products that really matter.

The following development programs, relying on the regenerating potential of RGTA® molecules,  are just only a fraction of the technology’s potential, and are to date the closer to market.

The excellence and potential of OTR3’s Pipeline has been confirmed by awards and grants (H2020 SME Instrument, Medicen Label, ANR grant)

liseret1
liseret2
Pipeline
Pipeline

© 2022 – OTR3 – All rights reserved

ADDRESS

4, rue Française
75001 Paris, France

© 2022 – OTR3 – All rights reserved